Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 3, 2025PharmaceuticalsOpen Access

Breakthrough Advances in Beta-Lactamase Inhibitors: New Synthesized Compounds and Mechanisms of Action Against Drug-Resistant Bacteria

View Full Paper
Ask AI
Bookmark
Share

Authors

YHYa-Si HuangZunyi Medical UniversityHZHong ZhouNanjing Agricultural University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Huang et al. (2025) studied this question.

synapsesocial.com/papers/6a8333793efdfb27564cd93bhttps://doi.org/10.3390/ph18020206
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Synergistic effect of the novel β-lactamase inhibitor BLI-489 combined with imipenem or meropenem against diverse carbapenemase-producing carbapenem-resistant Enterobacterales2022 · 7 citations
  2. 2NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings2019 · 713 citations
  3. 3The in vitro and in vivo potential of metal-chelating agents as metallo-beta-lactamase inhibitors against carbapenem-resistant Enterobacterales2022 · 8 citations
  4. 4Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases2019 · 214 citations
  5. 5In vitro potency of xeruborbactam in combination with multiple β-lactam antibiotics in comparison with other β-lactam/β-lactamase inhibitor (BLI) combinations against carbapenem-resistant and extended-spectrum β-lactamase-producing Enterobacterales2023 · 43 citations